Skip to content

A study to compare the effect of Shigru tail navan nasya and Vidangadi dhum nasya in management of Vataj partishyaya w.s.r. to Allergic Rhinitis

A comparative study to evaluate the effect of Shigru tail navan nasya and Vidangadi dhum nasya in management of Vataj partishyaya w.s.r. to Allergic Rhinitis - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061972
Enrollment
40
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: J308- Other allergic rhinitis

Interventions

None listed

Sponsors

RGGPG Ayurvedic College and hospital Paprola Himachal Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A) age group between 12-80years B) presence of 2 or more nasal symptoms mentioned in clinical features of diagnostic criteria

Exclusion criteria

Exclusion criteria: 1. Patient below 12 years and above 80years 2. Those who are unfit for nasya karma as per clasical text 3. Patient with adenoid and polyp 4. Patient with dyslipidemia, hypertension, unstable cardiovascular and cerebrovascular conditions 5. Currently or previously treated for malignancy 6. Patient currently on antihistaminics or steroid therapy 7. Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
Relief in symptoms: kshavathu - paroxysmal sneezing Aanadha - nasal obstruction on and off Tanusrava- watery nasal discharge Shirashoola- headache Gal talushosha- dryness of throat and palate Nistodshankha- pricking pain in temporal region Swarbheda - hoarseness of voice and other associated symptoms like frequent cold, persistent stuffy nose chronic cough, post nasal discharge Timepoint: After 7 days On completion of trial i.e. on 15th day 15 days after the completion of trial

Secondary

MeasureTime frame
complete remission of sign & symptomTimepoint: After 7 days On completion of trial 15 days after completion of trial

Countries

India

Contacts

Public ContactRitika Rajgour

RGGPG Ayurvedic College and hospital Paprola

anil5karma@gmail.com9418466766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026